FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051267330> ?p ?o ?g. }

• W2051267330 endingPage "397" @default.
• W2051267330 startingPage "382" @default.
• W2051267330 abstract "Vox SanguinisVolume 16, Issue 5 p. 382-397 Human Plasma and Plasma Fractions as Sources of Factor VIII (Antihaemophilic Factor) M. Verstraete, Corresponding Author M. Verstraete Department of Medicine, Laboratory of Bloodcoagulation, University of Leuven, LeuvenDepartment of Medicine, Laboratory of Bloodcoagulation, University of Leuven, Leuven (Belgium).Search for more papers by this authorP. Olislaegers, Corresponding Author P. Olislaegers Department of Medicine, Laboratory of Bloodcoagulation, University of Leuven, LeuvenDepartment of Medicine, Laboratory of Bloodcoagulation, University of Leuven, Leuven (Belgium).Search for more papers by this authorH. van Itterbeek, Corresponding Author H. van Itterbeek Department of Medicine, Laboratory of Bloodcoagulation, University of Leuven, LeuvenDepartment of Medicine, Laboratory of Bloodcoagulation, University of Leuven, Leuven (Belgium).Search for more papers by this authorP. Waumans, Corresponding Author P. Waumans Department of Medicine, Laboratory of Bloodcoagulation, University of Leuven, LeuvenDepartment of Medicine, Laboratory of Bloodcoagulation, University of Leuven, Leuven (Belgium).Search for more papers by this authorA. Lust, Corresponding Author A. Lust Department of Medicine, Laboratory of Bloodcoagulation, University of Leuven, LeuvenDepartment of Medicine, Laboratory of Bloodcoagulation, University of Leuven, Leuven (Belgium).Search for more papers by this author M. Verstraete, Corresponding Author M. Verstraete Department of Medicine, Laboratory of Bloodcoagulation, University of Leuven, LeuvenDepartment of Medicine, Laboratory of Bloodcoagulation, University of Leuven, Leuven (Belgium).Search for more papers by this authorP. Olislaegers, Corresponding Author P. Olislaegers Department of Medicine, Laboratory of Bloodcoagulation, University of Leuven, LeuvenDepartment of Medicine, Laboratory of Bloodcoagulation, University of Leuven, Leuven (Belgium).Search for more papers by this authorH. van Itterbeek, Corresponding Author H. van Itterbeek Department of Medicine, Laboratory of Bloodcoagulation, University of Leuven, LeuvenDepartment of Medicine, Laboratory of Bloodcoagulation, University of Leuven, Leuven (Belgium).Search for more papers by this authorP. Waumans, Corresponding Author P. Waumans Department of Medicine, Laboratory of Bloodcoagulation, University of Leuven, LeuvenDepartment of Medicine, Laboratory of Bloodcoagulation, University of Leuven, Leuven (Belgium).Search for more papers by this authorA. Lust, Corresponding Author A. Lust Department of Medicine, Laboratory of Bloodcoagulation, University of Leuven, LeuvenDepartment of Medicine, Laboratory of Bloodcoagulation, University of Leuven, Leuven (Belgium).Search for more papers by this author First published: May 1969 https://doi.org/10.1111/j.1423-0410.1969.tb04765.xCitations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Anstall, H. B.; Grove-Rasmussen, M. and Shaw, R. S.: Optimal conditions for storage of fresh frozen plasma. Transfusion 1: 87 (1961). 2 Bidwell, E.: The purification of bovine anti-haemophilic globulin. Brit. J. Haemat. 1: 35 (1955). 3 Bidwell, E.: The purification of anti-haemophilic globulin from animal plasma. Brit. J. Haemat. 1: 386 (1955). 4 Biggs, R. and MacEarlane, R. G.: Treatment of haemophilia and other coagulation disorders (Blackwell, Oxford 1966). 5 Blomback, B.: Purification of anti-haemophilic globulin: I. Some studies on the stability of the anti-haemophilic activity in fraction 1-0 and a method for its partial separation from fibrinogen. Ark. Kemi. 12: 387 (1958). 6 Blomback, B.: Properties of anti-haemophilic factor; in Brinkhous The haemophilias, p. 118 (University of North Carolina Press, 1964). 7 Bradlow, B. A.; Ellis, B. C. and Abrahams, O. L.: Transfusion therapy in classical haemophilia. Med. Proc., Johannesburgh 6: 253 (1960). 8 Brinkhous, K. M.: Plasma anti-haemophilic factor: Biological and clinical aspects. Sang. 25: 738–741 (1954). 9 Brinkhous, K. M.:. 10 Britten, A. and Grove-Rasmussen, M.: Stability of factor VIII in the frozen state. Transfusion 6: 230–233 (1966). 11 Brown, D. L.; Hardisty, R. M.; Kosoy, M. H. and Bracken, C.: Anti-haemophilic globulin: Preparation by an improved cryoprecipitation method and clinical use. Brit. Med. J. 2: 79–85 (1967). 12 Cohn, E. J.: Preparation and properties of serum and plasma proteins: IV. System for separation into fractions of protein and lipoproteins components of biological fluids. J. Amer. Chem. Soc. 6: 459–475 (1946). 13 Hawkey, C. M.; Férete, L. and Shanbrom, E.: Preparation of a stable AHF concentrate suitable for direct syringe infusion (to be published, 1967). 14 Hawkey, C. M.; Anstall, H. B. and Grove-Rasmussen, M.: A study of comparative antihaemophilic factor levels in fresh frozen plasma in vitro and in vivo. Transfusion 2: 94 (1962). 15 Heyl, J. T.; Gibson, J. G. and Janeway, C. A.: Studies on the plasma protein: V. The effect of concentrated solutions of human and bovine serum albumin on blood volume after acute blood loss in man. J. clin. Invest. 30: 1228 (1943). 16 Ingram, G. I. C.: Major surgery in haemophilia. Use of animal antihaemophilic factor in Britain. Transfusion 2: 88 (1963). 17 Johnson, A. J.; Newman, J.; Howell, M. B. and Puszkin, S.: in Brinkhous Purification of antihaemophilic factor (AHF) for clinical and experimental use in platelets: their role in haemostasis and thrombosis, p. 377 (Schattauer, Stuttgart 1967). 18 Keckwick, R. A. and Wolf, P.: A concentrate of human antihaemophilic factor: Its use in six cases of haemophilia. Lancet i: 647–650 (1957). 19 Koppe, J. G.: Haemophilia. Experience with the preparation and administration of a two donor fibrinogen; med. diss. Amsterdam (1964). 20 MacFarlane, R. G.; Mallam, P. C.; Witts, L. J.; Bidwell, E.; Bigg, R.; Fraenkel, G. J.; Honey, G. E. and Taylor, K. B.: Surgery in haemophilia. The use of animal antihaemophilic globulin and human plasma in thirteen cases. Lancet ii: 251 (1957). 21 Marder, V. J. and Shulman, N. R.: Major surgery in classic haemophilia using Fraction I. Experience in twelve operations and review of the literature. Amer. J. Med. 41: 56 (1966). 22 McMillan, C. W.; Diamond, L. K. and Surgenor, D. M.: Treatment of classic haemophilia: the use of fibrinogen rich in factor VIII for hemorrhage and for surgery. New Engl. J. Med. 265: 224 (1961). 23 Meyer, K.; Eernisse, J. G.; Veltkamp, J. J.; Hemker, H. C. and Loeliger, E. A.: Treatment of haemophilia. A with purified Factor VIII obtained from human plasma by cryoprecipitation. Folia Med. neerl. 10: (1967). 24 Michael, S. E. and Tunnah, G. W.: The purification of Factor VIII (anti-haemophilic globulin). Brit. J. Haemat. 9: 236 (1963). 25 Mirick, G. S.; Ward, R. and McCollum, R. W.: Modification of post-transfusion hepatitis by gamma globulin. New Engl. J. Med. 273: 59 (1965). 26 Morrison, F. S.: Factor VIII (AHF) Concentration in pH 6.5 citrate plasma. Blood 28479 (1966). 27 Nitschmann, H. G.; Kistler, J. P. and Joss, A.: Dried fraction I for clinical use from smallest plasma pools sterile without filtration. Vox. Sang. 2: 100 (1957). 28 Pavlovsky, A.: Use of plasmatic concentrate (Fi-O-Fa) in the treatment of haemophilia. III International Pharmacological Congress, July 1966, Sao Paulo, Brazil. 29 Pavlovsky, A.; De Pinto, Tezanos M. and Canaveri, Martinez A.: Clinical experience with transfusions of FI-O-Ta; in Brinkhous Platelets: their role in haemostasis and thrombosis, p. 383 (Schattauer, Stuttgart 1967). 30 Pool, J. G. and Robinson, J.: Assay of plasma antihaemophilic globulin (AHG). Brit. J. Haemat. 5: 17–23 (1959). 31 Pool, J. G.; Hershsold, E. J. and Pappenhasen, A.: High-potency antihaemophilic factor concentrate prepared from cryoglobulin precipitate. Nature 203: 312 (1964). 32 Pool, J. G. and Shannon, A. E.: Production of High-potency concentrates of antihaemophilic globulin in a closed-bag system, Assay in vitro and in vivo. New Engl. J. Med. 273: 1443–1447 (1965). 33 Pool, J. G.: The effect of several variables on cryoprecipitated factor VIII (AHG) concentrates. Transfusion 1: (1967). 34 Preston, A. E. and Barr, A.: The plasma concentration of Factor VIII in the normal population: II. The effects of age, sex and blood group. Brit. J. Haemat. 10: 238 (1964). 35 Preston, A. E.: In Biggs and MacFarlane Treatment of haemophilia and other coagulation disorders (Blackwell, Oxford, 1966). 36 Ratnoff, O. D.; Botti, R. E.; Breckenridge, R. T. and Littell, A. S.: In Brinkhous The haemophilias, p. 3 (Chapell Hill, North Carolina 1964). 37 Rizza, C. R.: Effect of exercise on the level of antihaemophilic globulin in human blood. J. Physiol., Lond. 356: 217 (1961). 38 Simonetti, C.; Casillas, G. et Pavlovsky, A.: Purification du facteur VIII antihémophilique (FAH). Hémostase 1: 57 (1961). 39 Spaet, T. H. and Carner, E. S.: Studies on the storage lability of human antihaemophilic factor. J. Lab. clin. Med. 46: 111 (1955). 40 van Creveld, S. en Mochtar, I. A.: Plasmatransfusies bij hemofilie VIII. Het effect van verschillende plasmaprodukten bij hemofilie A. Ned. T. Geneesk. 107: 155 (1963). 41 Wagner, R. H.; McLester, W. D.; Schmith, M. and Brinkhous, K. M.: Purification of antihaemophilic factor (Factor VIII) by amino acid precipitation. Thromb. Diath. Haemorrh. 11: 64 (1964). 42 Wagner, R. H.: Reports of the subcommittee on human Factor VIII (AHF) preparation; in Brinkhous Platelets: their role in haemostasis and thrombosis, p. 371–375 (Schattauer Verlag, Stuttgart 1967). 43 Ware, A. G.; Guest, M. M. and Seegers, W. H.: Fibrinogen, with special reference to its preparation and certain properties of the product. Arch. Biochem. 13: 231–236 (1947). 44 Waumans, P.; van Itterbeek, R. and Verstraete, M.: The preparation of a human plasma fraction by cryoprecipitation and its use in haemophilia. Acta clin. belg. (1968). 45 Weaver, R. A. and Langdell, R. D.: Antihaemophilic Factor (AHF) stability in fresh frozen blood bank plasma. (1966). Citing Literature Volume16, Issue5May 1969Pages 382-397 ReferencesRelatedInformation" @default.
• W2051267330 created "2016-06-24" @default.
• W2051267330 creator A5001446916 @default.
• W2051267330 creator A5010067916 @default.
• W2051267330 creator A5010817039 @default.
• W2051267330 creator A5076590573 @default.
• W2051267330 creator A5083967053 @default.
• W2051267330 date "1969-05-01" @default.
• W2051267330 modified "2023-10-17" @default.
• W2051267330 title "Human Plasma and Plasma Fractions as Sources of Factor VIII (Antihaemophilic Factor)" @default.
• W2051267330 cites W114280679 @default.
• W2051267330 cites W1944929310 @default.
• W2051267330 cites W1987218726 @default.
• W2051267330 cites W1987600164 @default.
• W2051267330 cites W1988863786 @default.
• W2051267330 cites W1990399719 @default.
• W2051267330 cites W2006155425 @default.
• W2051267330 cites W2025489578 @default.
• W2051267330 cites W2067689996 @default.
• W2051267330 cites W2082534510 @default.
• W2051267330 cites W2083017360 @default.
• W2051267330 cites W2087659458 @default.
• W2051267330 cites W2089230634 @default.
• W2051267330 cites W2117112510 @default.
• W2051267330 cites W2161957306 @default.
• W2051267330 cites W2166940722 @default.
• W2051267330 cites W2319306274 @default.
• W2051267330 cites W2328767259 @default.
• W2051267330 cites W2404356758 @default.
• W2051267330 cites W2416625011 @default.
• W2051267330 cites W4253180455 @default.
• W2051267330 cites W84443160 @default.
• W2051267330 doi "https://doi.org/10.1111/j.1423-0410.1969.tb04765.x" @default.
• W2051267330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/5800592" @default.
• W2051267330 hasPublicationYear "1969" @default.
• W2051267330 type Work @default.
• W2051267330 sameAs 2051267330 @default.
• W2051267330 citedByCount "4" @default.
• W2051267330 crossrefType "journal-article" @default.
• W2051267330 hasAuthorship W2051267330A5001446916 @default.
• W2051267330 hasAuthorship W2051267330A5010067916 @default.
• W2051267330 hasAuthorship W2051267330A5010817039 @default.
• W2051267330 hasAuthorship W2051267330A5076590573 @default.
• W2051267330 hasAuthorship W2051267330A5083967053 @default.
• W2051267330 hasConcept C121332964 @default.
• W2051267330 hasConcept C16685009 @default.
• W2051267330 hasConcept C185592680 @default.
• W2051267330 hasConcept C199360897 @default.
• W2051267330 hasConcept C2781039887 @default.
• W2051267330 hasConcept C3020134792 @default.
• W2051267330 hasConcept C41008148 @default.
• W2051267330 hasConcept C43617362 @default.
• W2051267330 hasConcept C62520636 @default.
• W2051267330 hasConcept C71924100 @default.
• W2051267330 hasConcept C82706917 @default.
• W2051267330 hasConceptScore W2051267330C121332964 @default.
• W2051267330 hasConceptScore W2051267330C16685009 @default.
• W2051267330 hasConceptScore W2051267330C185592680 @default.
• W2051267330 hasConceptScore W2051267330C199360897 @default.
• W2051267330 hasConceptScore W2051267330C2781039887 @default.
• W2051267330 hasConceptScore W2051267330C3020134792 @default.
• W2051267330 hasConceptScore W2051267330C41008148 @default.
• W2051267330 hasConceptScore W2051267330C43617362 @default.
• W2051267330 hasConceptScore W2051267330C62520636 @default.
• W2051267330 hasConceptScore W2051267330C71924100 @default.
• W2051267330 hasConceptScore W2051267330C82706917 @default.
• W2051267330 hasIssue "5" @default.
• W2051267330 hasLocation W20512673301 @default.
• W2051267330 hasLocation W20512673302 @default.
• W2051267330 hasOpenAccess W2051267330 @default.
• W2051267330 hasPrimaryLocation W20512673301 @default.
• W2051267330 hasRelatedWork W1531601525 @default.
• W2051267330 hasRelatedWork W2319480705 @default.
• W2051267330 hasRelatedWork W2384464875 @default.
• W2051267330 hasRelatedWork W2398689458 @default.
• W2051267330 hasRelatedWork W2606230654 @default.
• W2051267330 hasRelatedWork W2607424097 @default.
• W2051267330 hasRelatedWork W2748952813 @default.
• W2051267330 hasRelatedWork W2899084033 @default.
• W2051267330 hasRelatedWork W2948807893 @default.
• W2051267330 hasRelatedWork W2778153218 @default.
• W2051267330 hasVolume "16" @default.
• W2051267330 isParatext "false" @default.
• W2051267330 isRetracted "false" @default.
• W2051267330 magId "2051267330" @default.
• W2051267330 workType "article" @default.